Hydroboration of [(1R*,2R*,4R*)-7-oxabicyclo[2.2.1]hept-5-en-2-yl]methyl benzoate (5), which was prepared by Diels–Alder reaction of furan with acrolein and subsequent reduction and benzoylation of the Diels–Alder product, afforded [(1R*,2S*,4S*,6S*)-6-hydroxy-7-oxabicyclo[2.2.1]heptan-2-yl]methyl benzoate (6) and [(1R*,2R*,4R*,5S*)-5-hydroxy-7-oxabicyclo[2.2.1]heptan-2-yl]methyl benzoate (7). The key intermediates, [(1R*,2S*,4S*,6R*)-6-hydroxy-7-oxabicyclo[2.2.1]heptan-2-yl]methyl benzoate (10) and [(1R*,2R*,4R*,5R*)-5-hydroxy-7-oxabicyclo[2.2.1]heptan-2-yl]methyl benzoate (11), were prepared from6and7, respectively, by oxidation with pyridinium dichromate and subsequent reduction of the thus obtained ketones. The Mitsunobu reaction of10and11with 6-chloropurine and subsequent reductive deprotection with diisobutylaluminium hydride afforded 6-chloropurine derivatives, which were converted to other purine analogues. Thymine analogues were prepared by Mitsunobu reaction of10and11with 3-benzoyl-5-methylpyrimidine-2,4(1H,3H)-dione and subsequent methanolysis. The target compounds were tested for the activity againstCoxsackievirus.
将[(1R*,2R*,4R*)-7-氧杂双环[2.2.1]庚-5-烯-2-基]甲基苯甲酸酯(5),通过呋喃与丙烯醛的Diels-Alder反应制备,随后还原和苯甲酰化Diels-Alder产物,进行氢硼化反应,得到[(1R*,2S*,4S*,6S*)-6-羟基-7-氧杂双环[2.2.1]庚-2-基]甲基苯甲酸酯(6)和[(1R*,2R*,4R*,5S*)-5-羟基-7-氧杂双环[2.2.1]庚-2-基]甲基苯甲酸酯(7)。关键中间体[(1R*,2S*,4S*,6R*)-6-羟基-7-氧杂双环[2.2.1]庚-2-基]甲基苯甲酸酯(10)和[(1R*,2R*,4R*,5R*)-5-羟基-7-氧杂双环[2.2.1]庚-2-基]甲基苯甲酸酯(11),分别通过吡啶二铬酸盐氧化和随后还原所得酮制备自6和7。将10和11与6-氯嘌呤进行Mitsunobu反应,随后用二异丁基铝氢化物进行还原去保护作用,得到6-氯嘌呤衍生物,可转化为其他嘌呤类似物。通过10和11与3-苯甲酰-5-甲基嘧啶-2,4(1H,3H)-二酮进行Mitsunobu反应,随后进行甲醇解,制备嘧啶类似物。对目标化合物进行了对柯萨奇病毒活性的测试。